Global nutrition group Glanbia said its business grew by nearly 7% between the months of January and September.
In a trading update this morning, the company reiterated its full-year guidance on earnings per share of between 5% and 8%.
Glanbia said that in the nine months to September 29, wholly owned revenue from continuing operations increased by 3.7% constant currency basis.
But pricing declined by 4.1% compared to the same time last year due to relatively weaker dairy markets and brand investment.
Siobhán Talbot, Glanbia's group managing director, said that the year is progressing as planned.
"We continue to execute our strategy and, in addition to growth in our core business, we recently announced the acquisition of SlimFast which will further enhance our portfolio," Ms Talbot added.
The Glanbia Performance Nutrition division saw revenue growth of 4.7% in the first nine months of the year on the back of volume growth of 6.7% which offset a price decline of 4.4%.
Glanbia said the full year outlook for the division is good. "Guidance is reiterated for the delivery of like-for-like branded volume growth in the mid-to-high single digit range," it stated.
The Glanbia Nutritionals division delivered revenue growth of 3% in the nine month period, which was driven by a volume increase of 6.8% which was offset by a price decline of 3.8%.
Glanbia also noted that its US Cheese business saw revenues rise by 4.8% in the nine month period on the back of volume growth of 6.4% and a pricing decline of 1.6%.
The company said its net debt at the end of September stood at €398m, a decrease of €84m compared to the same time last year.
Shares in the company were lower in Dublin trade today.
